CINECA IRIS Institutional Research Information System

PICH, Achille
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 15.015
NA - Nord America 5.580
AS - Asia 2.157
AF - Africa 55
SA - Sud America 42
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 15
Totale 22.890
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 10.206
US - Stati Uniti d'America 5.421
CN - Cina 1.144
UA - Ucraina 829
DE - Germania 675
IE - Irlanda 665
FR - Francia 644
SE - Svezia 482
FI - Finlandia 405
KR - Corea 344
GB - Regno Unito 318
PL - Polonia 231
SG - Singapore 209
DK - Danimarca 166
JP - Giappone 145
CA - Canada 135
VN - Vietnam 105
AT - Austria 84
CH - Svizzera 70
IN - India 65
ES - Italia 45
TR - Turchia 37
SN - Senegal 36
BE - Belgio 35
NL - Olanda 34
AU - Australia 25
RU - Federazione Russa 25
MX - Messico 20
BR - Brasile 18
HK - Hong Kong 18
IR - Iran 18
EU - Europa 15
RO - Romania 15
GR - Grecia 12
TH - Thailandia 12
CZ - Repubblica Ceca 11
NO - Norvegia 10
QA - Qatar 10
TW - Taiwan 10
CO - Colombia 9
IL - Israele 8
PT - Portogallo 8
AL - Albania 7
CL - Cile 7
EG - Egitto 7
MY - Malesia 7
ID - Indonesia 6
SK - Slovacchia (Repubblica Slovacca) 6
SM - San Marino 6
BY - Bielorussia 5
HR - Croazia 5
KW - Kuwait 5
PK - Pakistan 5
SD - Sudan 4
AE - Emirati Arabi Uniti 3
AR - Argentina 3
BD - Bangladesh 3
BG - Bulgaria 3
EE - Estonia 3
ZA - Sudafrica 3
DZ - Algeria 2
EC - Ecuador 2
LT - Lituania 2
LU - Lussemburgo 2
MD - Moldavia 2
NI - Nicaragua 2
PE - Perù 2
SA - Arabia Saudita 2
BO - Bolivia 1
BW - Botswana 1
CR - Costa Rica 1
CV - Capo Verde 1
HU - Ungheria 1
IM - Isola di Man 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PR - Porto Rico 1
RS - Serbia 1
SI - Slovenia 1
Totale 22.890
Salva come PNG Salva come JPEG
Città #
Beijing 843
Dublin 662
Milan 659
Chandler 569
Rome 512
Jacksonville 493
Houston 311
Medford 259
Fairfield 236
Villeurbanne 224
Torino 212
Ann Arbor 208
Princeton 203
Warsaw 194
Wilmington 181
Ashburn 172
Dearborn 170
Nyköping 154
Singapore 121
Florence 117
Naples 113
Palermo 110
Woodbridge 105
Pisa 100
Verona 98
Redwood City 95
Bologna 92
Los Angeles 90
Turin 90
Seattle 89
Cambridge 85
Vienna 80
Toronto 79
Dong Ket 70
Bari 65
Catania 65
Padova 60
Boston 58
Napoli 54
Perugia 48
Tokyo 46
Genoa 45
Fremont 43
Lachine 43
Boardman 41
Brescia 39
Dallas 37
Falls Church 35
Genova 35
Shanghai 33
Trieste 31
Mountain View 29
Norwalk 29
Guangzhou 27
Parma 27
Cagliari 25
Pescara 25
Nanjing 23
Vicenza 23
Monza 20
Busto Arsizio 19
Messina 19
Modena 19
Rimini 19
San Mateo 19
Zurich 19
Bergamo 18
Treviso 18
Latina 17
New York 17
Reggio Emilia 17
Zhengzhou 17
Taranto 16
Brussels 15
Hefei 15
Helsinki 15
Livorno 15
Mumbai 15
Ravenna 15
Ancona 14
Como 14
Pune 14
Hangzhou 13
Lucca 13
Sassari 13
Spoltore 13
Venezia 13
Jesi 12
Paris 12
San Diego 12
Siena 12
Buffalo 11
Halle 11
Hebei 11
Kunming 11
San Giuliano Milanese 11
Trento 11
Altamura 10
Doha 10
Düsseldorf 10
Totale 9.377
Salva come PNG Salva come JPEG
Nome #
Nevo blu cellulare maligno 7.592
L’attività proliferativa nei tumori del capo-collo. 2.203
Significato degli AgNORs in patologia tumorale. 390
Core binding factor acute myeloid leukaemia and c-KIT mutations 380
Description of a novel Janus kinase 3 P132A mutation in acute megakaryoblastic leukemia and demonstration of previously reported Janus kinase 3 mutations in normal subjects. 327
JAK2V617F activating mutation is associated with the myeloproliferative type of chronic myelomonocytic leukaemia 325
Thymic epithelial tumors express vascular endothelial growth factors and their receptors as potential targets of antiangiogenic therapy: A tissue micro array-based multicenter study. 270
Novel CALR somatic mutations in essential thrombocythaemia 228
Myelodysplastic syndrome with del (5q) and JAK2V617F mutation transformed to acute myeloid leukaemia with complex karyotype 215
Essential Differences in Clinical and Bone Marrow Features in BCR/ABL- Positive Thrombocythemia Compared to Thrombocythemia in the BCR/ABL -Negative Myeloproliferative Neoplasms Essential Thrombocythemia and Polycythemia Vera. 193
JAK2V617F mutation and allele burden are associated with distinct clinical and morphological subtypes in patients with essential thrombocythaemia 189
Prognostic relevance of cell proliferation in head and neck tumors 186
WHO Clinical Molecular and Pathological (WHO-CMP) Features of Congenital MPLS505N and the Acquired MPL W515l/K Mutated Essential Thrombocythemia and Myelofibrosis 165
JAK2V617F, CALR, and MPL Mutations and Bone Marrow Histology in Patients with Essential Thrombocythaemia 163
Significato prognostico della attività proliferativa, valutata con conteggio delle regioni organizzatrici del nucleolo (NORs), nella leucemia acuta mieloblastica (LAM) dell’adulto 156
Expression of angiogenesis-related biomarkers in thymic epithelial tumors (TET). 145
The Dilemma of HER2 Double-equivocal Breast Carcinomas: Genomic Profiling and Implications for Treatment 133
Nevo Blu Cellulare Neuro neuroide 132
Chronic myelomonocytic leukaemia with marked thrombocytosis and JAK2V617F mutation transformed into an acute megakaryoblastic leukaemia. 132
KIT and PDGFRA mutations and PDGFRA immunostaining in gastrointestinal stromal tumors 127
EFFECT ON CLINICAL OUTCOME OF BONE MARROW RETICULIN FIBROSIS IN 579 PATIENTS WITH POLYCYTHEMIA VERA AND ESSENTIAL THROMBOCYTHEMIA 123
Utilità della citologia esfoliativa orale per la diagnosi di displasia e carcinoma squamoso orale: confronto tra esame citologico tradizionale ed in fase liquida (“Strato sottile”). 121
Sopravvivenza di soggetti affetti da mieloma in relazione al quadro istologico osteo-midollare 117
Neoplasie papillari superficiali della vescica. Parametri morfologici e biologici correlati con recidive 113
Core binding factor acute myeloid leukemia and c-kit mutations 113
Prognostic value of the rapidity of bone marrow blast cell proliferation in adult acute lymphoblastic leukemia 107
Intrasinusoidal bone marrow infiltration and splenic marginal zone lymphoma: a quantitative study 103
Refractory cytopenia with multilinear dysplasia (RCMD) in patient with Fanconi anaemia 100
Prognostic value of quantitative analysis of WT1 gene transcripts in adult acute lymphoblastic leukemia 99
Wiskott–Aldrich syndrome protein (WASP) is a tumor suppressor in T cell lymphoma 98
Autosomal Dominant Hereditary Essential Thrombocythemia due to a Gain of Function Mutation in the Thrombopoietin (TPO) and JAK2 Gene as the Cause of Congenital Aspirin-Responsive Sticky Platelet Syndrome: Personal Experiences and Review of the Literature 94
Linfomi non-Hodgkin di piccole cellule primitivi della milza: infiltrazione midollare intrasinusoidale come modalità caratteristica di invasione 92
Correlative studies on the presence of oestrogen and prolactin receptors and histology in human breast carcinomas 86
LAT (linker for activation of T cells): un utile marcatore per l’identificazione di megacariociti in biopsie osteomidollari. 84
Myelodysplastic syndrome with isolated del (5q) and JAK2V617F mutation transformed into an acute myeloid leukemia. 84
JAK2V617F mutation and allele burden: correlation with morphologic and clinical features and response to therapy in patients with essential thrombocytemia. 84
Bcl-2 expression in male breast carcinoma. 81
Biologic differences between noninvasive papillary urothelial neoplasms of low malignant potential and low-grade (grade 1) papillary carcinomas of the bladder. 80
Argyrophilic nucleolar organizer region counts and proliferating cell nuclear antigen scores are two reliable indicators of survival in pharyngeal carcinoma 79
Parametri biologici di malignità nei linfomi di piccole cellule CD5 positivi 76
Angiogenic activity of hyperplastic and neoplastic lymph nodes 76
Gli AgNOR in citologia esfoliativa orale 76
Utilità diagnostica del conteggio degli Organizzatori Nucleolari nella valutazione citologica dei versamenti neoplastici 75
AgNORs and myeloma prognosis. 74
AgNORs, nuclear and nucleolar morphometry in prostate carcinoma 73
Significato prognostico degli organizzatori nucleolari (AgNORs) nei carcinomi del seno piriforme 73
JAK2 V617F activating mutation in chronic myelomonocytic leukemia 73
Prognostic value of nucleolar organizer region count in non-invasive thymomas 73
Argyrophilic nucleolar organizer region counts and Ki-67 scores in human renal cell carcinoma. 72
Prognostic relevance of AgNORs in tumor pathology 72
Attività proliferativa di carcinomi di epitelio transizionale della vescica indagata mediante l'analisi degli Organizzatori Nucleolari e la marcatura con l'anticorpo monoclonale anti PCNA (PC10) 72
L'osteodistrofia uremica: correlazione tra dati clinici, radiologici ed istologici in un gruppo di pazienti 70
Argyrophilic nucleolar organizer region counts in malignant melanoma associated with benign intradermal nevus. 69
Autopsy and multiple pathology in the elderly 69
p53 protein expression in patients with myelodysplasia treated with allogeneic bone marrow transplantation 69
Androgen receptor expression in male breast carcinoma: lack of clinicopathological association. 69
Significato delle AgNOR in patologia tumorale. 68
Anatomia Patologica 68
Prognostic value of AgNORs in renal cell carcinoma: results of a prospective study 68
Attività proliferativa dei carcinomi renali e vescicali indagata mediante l'anticorpo monoclonale Ki67 e l'analisi degli organizzatori nucleolari 67
Angiogenesi indotta da tessuto linfatico neoplastico evidenziata con impianto irideo. 67
Studio istologico dei fenomeni riparativi di ulcere distrofiche trattate con Ossigeno ad alte dosi 67
Clinical significance of AgNOR counts in adult acute non-lymphoblastic leukaemia 66
Alterazioni istologiche del midollo osseo nei pazienti affetti da insufficienza renale cronica sottoposti a dialisi 66
Relationship between AgNORs, MIB-1 and oncogene expression in male breast carcinoma and papillary superficial bladder neoplasm. 65
Acute myelofibrosis and megakaryoblastic leukemia: an immunohistochemical study on bone marrow trephine biopsies 65
Follow-up of 24 cervical condylomata immunocytochemically positive for PV-Ag according to the virus type 65
Prognostic value of AgNOR counting. A prospective study in a series of renal cell carcinomas. 64
Intrasinusoidal bone marrow infiltration and splenic marginal zone lymphoma 63
Nucleolar organiser regions in bone marrow biopsies of patients with acute myelogeneous leukaemia 63
Argyrophilic nucleolar organizer region counts and prognosis in multiple myeloma 63
Authors response to Tripodo et al. "Reply to Pich et al.: Intrasinusoidal bone marrow infiltration and splenic marginal zone lymphoma: a quantitative study." 62
A computer network-based system for local storage and nationwide processing of autopsy diagnoses 62
Estensione della coilocitosi e positività immunoistochimica per il virus del papilloma in biopsie di condilomi della cervice uterina 62
DNA Flow Cytometry, Ki67 and Proliferating Cell Nuclear Antigen (PCNA-PC10) scores in intermediate grade malignant lymphomas 62
Androgen receptors in male breast carcinoma 62
The diagnostic value of histological findings in cervical condylomata immunohistochemically positive for papilloma virus (HPV) 62
Argyrophilic nucleolar organizer region counts predict survival in thymoma. 62
Correlation between argyrophilic nucleolar organizer region counts and labelling index in multiple myeloma 62
JAK2V617F MUTATIONAL STATUS IS ASSOCIATED WITH DIFFERENT PHENOTYPES IN ESSENTIAL TROMBOCYTHEMIA 62
Argyrophilic nucleolar organizer region counts in multiple myeloma: a histopathological study on bone marrow trephine biopsies 62
Tyrosine phosphatases regulate resistance to ALK inhibitors in ALK+ anaplastic large cell lymphoma 62
Argyrophilic nucleolar organiser region counts and prognosis in pharyngeal carcinoma. 61
Experimental investigation on histocompatibility of bovine collagen in rat tongue 61
[Evolution of acute leukemia in myelodysplastic syndromes: prognostic histopathological factors in a series of bone marrow biopsies] 61
Attività proliferativa di linfomi maligni di gruppo intermedio valutata con l'analisi del DNA e la marcatura con gli anticorpi monoclonali Ki67 e anti PCNA (PC10) 60
JAK2V617F, CALR and MPL mutations and bone marrow histology in patients with essential thrombocythemia. 60
Analysis of nucleolar organizer regions is predictive of complete remission in patients with acute myeloid leukemia 59
Proliferative activity is a significant prognostic factor in male breast carcinoma. 59
Discrasie delle plasmacellule e gammopatie 58
In male breast carcinoma DNA flowcytometric ploidy correlates with proliferative activity and prognosis 58
Bone marrow histopathology and prognosis in malignant lymphomas. 58
Argyrophilic nucleolar organizer regions (AgNORs) counts, proliferating cell nuclear antigen (PCNA) scores and DNA flow cytometry of bladder urotheliomas in routinely treated biopsies 58
AgNOR proliferation index and development of hepatocellular carcinoma in cirrhosis 57
Cell proliferation, bcl-2, c-myc, p53 and apoptosis as indicators of different aggressiveness in small lymphocytic lymphoma (SLL) 57
Valutazione dell'attività Timidina-chinasica nei liquidi di versamenti come controllo dell'accuratezza diagnostica citologica 57
Therapy and survival in male breast carcinoma: A retrospective analysis of 50 cases. 56
Valutazione degli AgNORs e di MIB-1 quali fattori prognostici dei carcinomi del seno piriforme sottoposti a radioterapia 56
Correlazione tra Regioni Organizzatrici del Nucleolo e Indice di marcatura delle plasmacellule in pazienti affetti da mieloma multiplo 56
AgNORs in melanomi associati a nevi intradermici 56
Totale 19.455
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.316
article - articoli 0
book - libri 0
conference - conferenze 24.349
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.665
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.411 190 212 375 261 404 402 345 208 365 179 266 204
2020/20213.110 380 156 284 171 240 178 295 141 398 292 231 344
2021/20222.353 174 141 140 149 131 114 192 156 133 139 335 549
2022/20233.585 360 194 140 285 292 753 357 275 345 130 220 234
2023/20242.892 279 234 103 146 112 147 275 162 52 317 449 616
2024/2025248 248 0 0 0 0 0 0 0 0 0 0 0
Totale 23.465